Alpha Asfotase Supply
Original notice title
Poland – Various medicinal products – DOSTAWA ASFOTAZY ALFA
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
Bid bond of 252,456 PLN is substantial and may not be recoverable if offer is withdrawn or if bidder fails to sign cont...
Strict pharmaceutical licensing requirements; winner must provide license within 10 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- Uniwersytecki Dziecięcy Szpital Kliniczny im. L. Zamenhofa w Białymstoku
- Country
- Poland
- CPV
- 33690000 - Various medicinal products
- Deadline
- Aug 18, 2026
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration 24 MONTH
- Supply of asfotase alfa injection solution (40 mg/ml) in three pack sizes: 0.45 ml (160 packs), 0.7 ml (30 packs), 1.0 ml (60 packs)
- Delivery to University Children's Clinical Hospital in Białystok, Poland
Show full summary
Open tender for the supply of asfotase alfa (asfotazy alfa) to a children's hospital in Białystok, Poland. Single lot, 24-month contract. Award based solely on lowest price. No estimated value published, but a high bid bond (252,456 PLN) is required. The buyer is a public hospital. EU funding status is inconsistent between structured data (EU-funded) and notice (no EU funds). Eligibility includes pharmaceutical licenses. Only Polish language is accepted.
Risks
Bid bond of 252,456 PLN is substantial and may not be recoverable if offer is withdrawn or if bidder fails to sign cont...
Strict pharmaceutical licensing requirements; winner must provide license within 10 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Bid bond (wadium) of 252,456 PLN required before deadline
Administrative
- Submission via e-ProPublico platform only
- Offer must be signed with qualified electronic signature
Award Criteria
Lot 1
Buyer
Location
Białystok, POL
Website
Buyer profile
Identifier
542-25-34-063
Activity
Health
Lots (1)
LOT-0001
Supply of asfotase alfa
Delivery of asfotase alfa injection solution in three pack sizes: 40 mg/ml 0.45 ml (160 packs), 0.7 ml (30 packs), and 1.0 ml (60 packs) over 24 months to the University Children's Clinical Hospital in Białystok.
Location
Duration
Category
Award Criteria
Deadline
Award details
Liczba punktów = ( Cmin/Cof ) * 100 * waga gdzie: - Cmin - najniższa cena spośród wszystkich ofert - Cof - cena podana w ofercie
Value note
Show original TED data
Original lot title
Dostawa asfotazy alfa
Original TED description
1 Asfotasum alfa roztw. do wstrzyk. 40 mg/ml 0,45 ml x 12 fiol. OP 160 2 Asfotasum alfa roztw. do wstrzyk. 40 mg/ml 0,7 ml x 12 fiol. OP 30 3 Asfotasum alfa roztw. do wstrzyk. 40 mg/ml 1,0 ml x 12 fiol. OP 60
Procurement Details
- Publication date
- 06 Jul 2026
- Languages
- Polish
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 466950-2026
Documents (1)
Similar tenders
Slovenia – Various medicinal products – Sukcesivna dobava zdravil za obdobje štirih let
Portugal – Various medicinal products – Aquisição de bens e medicamentos para a área de oftalmologia
Norway – Pharmaceutical products – Framework agreement for medicinal products and multi-doses for Sogndal
Poland – Various medicinal products – Dostawa produktów leczniczych określonych w 9 pakietach.
Poland – Various medicinal products – Dostawa produktów leczniczych
Norway – Pharmaceutical products – Medicines and multi-dose Narvik kommune - Framework agreement
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
Bid bond of 252,456 PLN is substantial and may not be recoverable if offer is withdrawn or if bidder fails to sign cont...
Strict pharmaceutical licensing requirements; winner must provide license within 10 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications